Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe study record history now shows a newer Revision: v3.6.3 replacing the previous Revision: v3.6.2. This reflects a minor administrative update to the page record rather than a substantive change to study data.SummaryDifference0.1%

- Check16 days agoChange DetectedThe History page shows a newer Revision tag (v3.6.2) in the footer, replacing the previous v3.6.0, indicating a recent page or site update rather than changes to the study data.SummaryDifference0.1%

- Check30 days agoChange DetectedThe record history now shows the study is no longer recruiting participants and introduces a new revision label (v3.6.0), while the previous revision (v3.5.5) is removed from the history.SummaryDifference0.4%

- Check37 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry, 'Revision: v3.5.4', was added to the record history. This updates the page's version label from the previous v3.5.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRecord History now lists Revision: v3.5.3 as the latest version, replacing v3.5.2. This indicates an updated version of the study record has been posted.SummaryDifference0.1%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.